ATLANTA, Jan. 20, 2005 (PRIMEZONE) -- Market Pulse News Alert for this AM, Stocks to Watch are: Lifestream Technologies, Inc. (OTCBB:LFTC), AVI Biopharma Inc. (Nasdaq:AVII), EntreMed, Inc. (Nasdaq:ENMD), and Beverly Enterprises Inc. (NYSE:BEV).
Investors need to be watching Lifestream Technologies, Inc. (OTCBB:LFTC) this AM! Lifestream develops, markets and sells a line of smart card-enabled healthcare diagnostic devices. Lifestream has developed and currently markets a line of cholesterol monitors that provide test results in three minutes for at-home use by health conscious consumers and at-risk medical patients. Lifestream just had excellent news out before today's opening bell regarding its concept product being unveiled at a recent FDA hearing! This could be great news for investors!
Lifestream Technologies, Inc. (OTCBB:LFTC), a leading supplier of cholesterol monitors, unveiled a concept product at the recent FDA hearing on an over-the-counter petition for cholesterol lowering drug. Lifestream has filed a patent application for its new product that reduces the cost for devices used for both the pharmacy and home testing. The technology under development looks like a computer mouse and embodies Lifestream's optic module and strip holder but uses a PC for the balance of the functionality.
"Lifestream is continually looking for ways to reduce the cost to our customers, as well as provide greater functionality for consumers and healthcare providers alike," said Christopher Maus, Lifestream's President and CEO. "We are exploring a prototype product that allows a user to plug a 'cholesterol mouse' into their PC with all functions actually performed by the computer hardware. The product's cost is reduced by eliminating LCD displays, microprocessors and keypads. Since the mouse is connected to the computer for its functionality, i.e., the data tracking software, the Health Risk Assessment, and data storage, information transfer to healthcare providers is quick, easy, transparent and simple. This technology would allow for easy software expansion to minimize the dating of any technology. Along with weighing this product's value in the marketplace, we are currently evaluating production, features, and if and when the product will debut. Lifestream realizes the impact home testing has on an individual's efforts to take control of their own health management program, and we look forward to bringing new products to the marketplace when they are determined to be suitable."
About Lifestream Technologies
The Company developed and currently markets a line of cholesterol monitors to consumers and healthcare professionals that provide test results in three minutes.
In addition to the professional monitor, the Company's product line aids the health conscious consumer in monitoring their risk of heart disease. By regularly testing cholesterol at home, individuals can monitor the benefits of their diet, exercise and/or drug therapy programs. Monitoring these benefits can support the physician and the individual's efforts to improve compliance. Lifestream's products also integrate a smart card reader further supporting compliance by storing test results on an individual's personal health card for future retrieval, trend analysis and assessment.
Lifestream's monitors are affordable, hand-held devices that provide users with accurate results in less than three minutes. The product line has been designed to accommodate The Data Concern(tm) Personal Health Card(r) allowing multiple users the ability to store their personal results. Lifestream's products are now available in pharmacy and retail outlets nationwide. To find retailers that carry Lifestream's products, go to "Store Locator" on www.knowitforlife.com or contact Customer Care at 888 954-LIFE. For Company information, visit www.lifestreamtech.com.
Stocks acting well as of late include: AVI Biopharma Inc. (Nasdaq:AVII), EntreMed, Inc. (Nasdaq:ENMD), and Beverly Enterprises Inc. (NYSE:BEV).
Information contained herein is the opinion of Market-Pulse.com ("MP") and is intended to be used strictly for informational purposes. You should be aware that MP attempts to assure itself of the accuracy of the information contained in the analyses it publishes. In this regard, MP does, at times, rely on the accuracy of information supplied to it by the companies which are the subject of MP's analyses and/or parties related to those companies. MP also relies on the accuracy and integrity of information that is contained in company press releases and reports filed with the SEC. The companies mentioned in this publication have not approved the content or timing of the information being published unless otherwise noted.
MP, because it relies on information supplied by various third parties disclaims any responsibility for the accuracy of such information. Any investor considering making an investment in any security which has been the subject of a MP analysis or opinion should, before making any such investment, consult with his/her market professional and/or do his/her own independent research regarding the company which is the subject of an MP opinion, recommendation or analysis.
Information regarding companies which MP has opined upon is normally available from many sources including the subject company's filings with the SEC and various press releases issued by the company.
You should be aware that MP is often compensated for issuing analyses, recommendations or opinions concerning particular companies. Its opinion is therefore not unbiased and you should consider this factor when evaluating MP's statements regarding a company. MP has been compensated in free trading shares of common stock, available for public trading as follows: Lifestream Technologies, Inc. compensation from a third party: three million free trading shares of stock in Lifestream Technologies, Inc., already delivered from a third party. MP has been compensated an additional three million restricted shares from Lifestream Technologies, Inc. To date, MP has sold three million shares of stock in Lifestream Technologies, Inc. for proceeds totaling ninety five thousand dollars. MP's officers and directors reserve the right to buy additional shares of the companies discussed in this opinion and may profit in the event those shares rise in value. When MP receives free trading shares as compensation for a profiled company, MP may sell part or all of any such shares during the period in which MP is performing such services. Market Pulse News Alert is a division of MP.